Diagnostic Imaging AI Services
Europe · 2 shared keywords
Updated
Reviewed by Vidhi Upadhyay
Europe AI Stroke Detection Market Industry Trends and Forecast to 2034: Segmented by (Modality, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$293.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $68.7 Mn | — | — |
| 2025 (base) | $81.4 Mn | +$12.7 Mn | — |
| 2026 (forecast) | $96.5 Mn | +$15.1 Mn | +18.5% |
| 2027 (forecast) | $114.4 Mn | +$17.9 Mn | +40.4% |
| 2028 (forecast) | $135.5 Mn | +$21.2 Mn | +66.4% |
| 2029 (forecast) | $160.6 Mn | +$25.1 Mn | +97.2% |
| 2030 (forecast) | $190.3 Mn | +$29.7 Mn | +133.7% |
| 2031 (forecast) | $225.5 Mn | +$35.2 Mn | +176.9% |
| 2032 (forecast) | $267.2 Mn | +$41.7 Mn | +228.1% |
| 2033 (forecast) | $316.7 Mn | +$49.4 Mn | +288.8% |
| 2034 (forecast) | $375.3 Mn | +$58.6 Mn | +360.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $81.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $375.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 18.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Modality and setting (see all) |
| Key players | Viz.ai, RapidAI, Brainomix, Methinks AI, Aidoc (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
AI stroke detection reads brain scans within minutes and alerts stroke teams so patients get treatment faster.
Key segments of the AI Stroke Detection market include modality (CT, CT Angiography and MRI) and setting (Comprehensive Stroke Centers, Community Hospitals and Mobile Stroke Units).
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI Stroke Detection market. Health systems are moving from pilots to wider use.
Generative AI, automation of paperwork and AI tools approved as medical devices give the AI Stroke Detection market strong growth, including in emerging health systems.
Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI Stroke Detection market.
The AI Stroke Detection market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device.[1] In some of the countries we cover here, rules for health software come from EU MDR and ANSM (France)[1], BfArM (DiGA) (Germany)[2], EU MDR and Ministry of Health (Italy)[1], EU MDR and AEMPS (Spain)[1] and MHRA (UK)[3]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[4]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] BfArM DiGA directory. Checked 14 Nov 2026.
[3] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[4] European Commission, health technology assessment. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI Stroke Detection market. Government digital health programs in Europe are speeding up adoption.
What doctors and scientists are doing in AI Stroke Detection right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 2 shared keywords
Europe
Europe
Europe
Europe
Europe
Pharmaceuticals · Europe
Medical Devices · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Medical Devices · Europe
Medical Devices · Europe